Management EfficiencyThe company has return on total asset (ROA) of (25.43) % which means that it has lost $25.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (73.44) % meaning that it generated substantial loss on money invested by shareholders.
Entity SummaryMauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Devices classification in France and traded on Paris Stock Exchange. It employs 90 people.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 90 people.
Mauna Kea Technologies Leadership Team
Stock Performance Indicators